The global biomaterials market is anticipated to value over USD 208 billion at a CAGR of over 14.2% during the forecast period 2019 to 2026. Biomaterials are mostly biological implants for therapeutic or diagnostic purposes. Some of the biomaterials are sutures, metallic joints, heart valves, tendons and so on. The biomaterials have become a vital tool in the medical sector and have demand across the globe. This has resulted in the biomaterials market growth. Rise in cardiovascular, orthopedic patient population is the key driver for biomaterials market growth and is influencing the CAGR positively. The efficacy of biomaterials in therapeutics and diagnostics is rising its preference by end-users. Natural biomaterials are anticipated to have a good margin in the market. The reduced risk of adverse effects, contamination and so on are the key factors for the rising demand for biomaterials in not only pharmaceutical but also in the cosmeceutical industry. The increased number of cardiac, orthopaedic and dental patients is one of the major factors influencing the growth of the biomaterials market across the globe. The cases of cardiac and orthopaedic implants are more as compared to others. Dental implants are also in demand for general treatments as well as for cosmeceutical purposes. The rising risk of cardiac diseases due to obesity and lifestyle habits is the driving force for North America and the Asia Pacific to dominate the biomaterials market. Furthermore, the major key players in the market have a widespread business in these regions. The major key players are Royal DSM, BASF SE, Corbion Berkeley Advanced Biomaterials, Inc., Cam Bioceramics B.V. and so on. Royal DSM is one of the dominating competitors of the biomaterials market. It has a range of advanced biomaterial products for cardiac, orthopaedic, ophthalmologic, etc medical conditions. FutureWise Key Takeaways: Investment in cardiac and orthopaedic biomaterials marketing Focus on natural biomaterials research Competitive Landscape: Tier 1 players- established companies in the market Laboratories and Agilent Technologies, Inc. with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants Global Biomaterials Market Segmentation: By Type: Metallic Polymeric Ceramic Natural biomaterials By Application: Cardiovascular Orthopaedic Ophthalmology Dental Plastic surgery Wound healing Tissue engineering Neurological/ central nervous system applications Other applications By Region: North America Europe Asia Pacific Objectives of the Study: To provide with an exhaustive analysis on the biomaterials market by type, by application and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific and Europe To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
The global biomaterials market is anticipated to value over USD 208 billion at a CAGR of over 14.2% during the forecast period 2019 to 2026.
Biomaterials are mostly biological implants for therapeutic or diagnostic purposes. Some of the biomaterials are sutures, metallic joints, heart valves, tendons and so on. The biomaterials have become a vital tool in the medical sector and have demand across the globe. This has resulted in the biomaterials market growth.
Rise in cardiovascular, orthopedic patient population is the key driver for biomaterials market growth and is influencing the CAGR positively. The efficacy of biomaterials in therapeutics and diagnostics is rising its preference by end-users.
Natural biomaterials are anticipated to have a good margin in the market. The reduced risk of adverse effects, contamination and so on are the key factors for the rising demand for biomaterials in not only pharmaceutical but also in the cosmeceutical industry.
The increased number of cardiac, orthopaedic and dental patients is one of the major factors influencing the growth of the biomaterials market across the globe. The cases of cardiac and orthopaedic implants are more as compared to others. Dental implants are also in demand for general treatments as well as for cosmeceutical purposes.
The rising risk of cardiac diseases due to obesity and lifestyle habits is the driving force for North America and the Asia Pacific to dominate the biomaterials market. Furthermore, the major key players in the market have a widespread business in these regions.
The major key players are Royal DSM, BASF SE, Corbion Berkeley Advanced Biomaterials, Inc., Cam Bioceramics B.V. and so on. Royal DSM is one of the dominating competitors of the biomaterials market. It has a range of advanced biomaterial products for cardiac, orthopaedic, ophthalmologic, etc medical conditions.
FutureWise Key Takeaways:
Competitive Landscape:
Global Biomaterials Market Segmentation:
By Type:
By Application:
By Region:
Objectives of the Study:
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
OR